1620 INVESTMENT ADVISORS, INC.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1907281
PLYMOUTH, MA
Position in BCRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,233
New position
Shares Held
1,180
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 50%
Shared 0%
None 50%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 20261620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
24,191 | $384,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
356 | $192,891 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
997 | $168,034 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,577 | $53,428 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
407 | $45,152 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
834 | $21,158 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
550 | $17,270 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
615 | $12,410 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,233 | 1,180 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||